Lexington, KY
- The revisions to its racing regulatory standards that were adopted by
the Association of Racing Commissioners International (ARCI) at its meeting
last month in New Orleans were formally posted today.
Among them, sections
pertaining to Medical Labeling were strengthened to ensure that improper
medications are not being used in racing and to strengthen racing commission
jurisdiction in this area.
ARCI Chair Judy
Wagner praised several racing industry organizations that provided invaluable
input to assist the development of the final medical labeling version that was
adopted. She noted specific contributions by the Racing Medication and Testing
Consortium, the National HBPA, the American Association of Equine
Practitioners, and the North American Association of Racetrack Veterinarians.
The Model Rules of
Racing were amended as follows:
• ARCI-004-105
Calculation Of Payouts And Distribution Of Pools
• ARCI-008-030
Jockey Suspensions and Designated Races
• ARCI-011-010
Treatment Restrictions
• ARCI-011-020
Medical Labeling
• ARCI-011-025
Trainer Responsibility
• ARCI-025-010
Treatment Restrictions
• ARCI-025-020
Medical Labeling
• ARCI-025-025
Trainer Responsibility
The ARCI also
expanded its Controlled Therapeutic Medication Schedule to include and set
regulatory thresholds for the following four medications: Cimetidine,
Ranitidine, Cetirizine and Guaifenesin.
Additionally, regulatory
thresholds for Xylazine and Omeprazole were modified based on new information
and research not available when the schedule was initially adopted. The
Xylazine and the Omeprazole thresholds were adjusted based upon studies
conducted at the University of California at Davis, funded by the Kentucky
Equine Drug Research Council, and coordinated through the Racing Medication and
Testing Consortium.
The ARCI also
amended the Uniform Classification Guidelines of (Prohibited) Foreign
Substances, as follows:
- Methamphetamine: Added
footnote language recommending Penalty B if testing can prove presence of
only levo-methamphetamine is present in sample.
- Tramadol: Penalty
recommendation changed from Penalty A to Penalty B.
- Cetirizine: Penalty
recommendation changed from Penalty B to Penalty C after inclusion into
ARCI Controlled Therapeutic Medication Schedule.
- Morphine: Footnote
language added recommending Penalty A if intentional administration can be proven by
regulators.
- Cocaine : Footnote
language added recommending Penalty A if intentional administration can be proven by
regulators.
All ARCI regulatory
standards are published on the association’s website: www.arci.com. Model Rules can also
be accessed through the University of Arizona’s Race Track Industry Program
(RTIP) at: http://ua-rtip.org/industry_service/arci_model_rules .
ARCI Model Rules
serve as a guide to jurisdictions in the making of racing regulatory policy.
In some instances, portions of the ARCI Model Rules have the force of
law by virtue of statutes or rules incorporating them “by reference”.
This means that when the ARCI adopts a rule, it automatically becomes the
applicable policy in jurisdictions that have done that.
Link to Version 6.2 of the ARCI
Model Rules: https://drive.google.com/file/d/0B2HwTiDKu_FHQjVNYy1xNk43VWs/view?usp=sharing
